This feature from Market Review by Ken Stephens analyzes the recent IPO rush amidst increasing economic worry. Several tech companies such as Lyft and Pinterest have recently filed to go public. For this week’s posts, click on the paragraph links.
Shalini Prakash, Venture Partner at 500 Startups, India, talks about the opportunities in the Indian market.
Sramana Mitra: How would you tackle the issue in any given community? Let’s say you’re a patient in any given community. Given your insurance and its coverage, there aren’t that many options. How do you deal with that in terms of provider choice? Ted Chan: What we’re trying to do is give a patient a
Sramana Mitra: How is it that you have 18 out of the top 25 pharma? Given what you describe, it seems to me like you should be having 25 out of the 25. Tareq Sherif: I agree with you. But it’s a business. Sramana Mitra: What is the explanation though? Tareq Sherif: The explanation is,
Sramana Mitra: Help me parse what you said about TripAdvisor. TripAdvisor is actually become a booking site. Isn’t that how they make most of their money? I haven’t been following their business model shift lately. Ted Chan: They look at it as a marketplace. When they show a sponsored listing, they are really showing it
Entrepreneurs are invited to the 438th FREE online 1Mby1M mentoring roundtable on Thursday, April 4, 2019, at 8 a.m. PDT/11 a.m. EDT/4 p.m. CET/8:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea. You’ll receive straightforward feedback, advice on next steps, and answers to any of your questions. Others
I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about Art and Culture. In this series, I will typically publish a piece of Art – a painting, a poem, a piece
Sramana Mitra: Have you started monetizing that? Have you started offering products on top of the datasets? Tareq Sherif: We actually have. Sramana Mitra: Give me an example. Tareq Sherif: There’s something called a synthetic control arm. In pretty much every clinical trial, you randomize patients. A patient comes in and you get put into